These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 32270866)
1. MIR600HG suppresses metastasis and enhances oxaliplatin chemosensitivity by targeting ALDH1A3 in colorectal cancer. Yao Y; Li N Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32270866 [TBL] [Abstract][Full Text] [Related]
2. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑487b‑3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3. Cheng M; Duan PG; Gao ZZ; Dai M Oncol Rep; 2020 Dec; 44(6):2691-2700. PubMed ID: 33125503 [TBL] [Abstract][Full Text] [Related]
4. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637. Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038 [TBL] [Abstract][Full Text] [Related]
5. LINC00982-encoded protein PRDM16-DT regulates Hu HF; Han L; Fu JY; He X; Tan JF; Chen QP; Han JR; He QY Theranostics; 2024; 14(8):3317-3338. PubMed ID: 38855188 [TBL] [Abstract][Full Text] [Related]
6. NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer. Chung HH; Lee CT; Hu JM; Chou YC; Lin YW; Shih YL Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707737 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis. Wang H; Li H; Zhang L; Yang D Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236 [TBL] [Abstract][Full Text] [Related]
8. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145. Gao R; Fang C; Xu J; Tan H; Li P; Ma L Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170 [TBL] [Abstract][Full Text] [Related]
9. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX. Hu J; Cai G; Xu Y; Cai S Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693 [TBL] [Abstract][Full Text] [Related]
10. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L. Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340 [TBL] [Abstract][Full Text] [Related]
11. ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells. Durinikova E; Kozovska Z; Poturnajova M; Plava J; Cierna Z; Babelova A; Bohovic R; Schmidtova S; Tomas M; Kucerova L; Matuskova M BMC Cancer; 2018 Aug; 18(1):848. PubMed ID: 30143021 [TBL] [Abstract][Full Text] [Related]
12. Circ_0000395 promotes cell growth, metastasis and oxaliplatin resistance by regulating miR-153-5p/MYO6 in colorectal cancer. Xiao L; Zhu Y; Xu H; Lin L; Li M; Zhou Y Pathol Res Pract; 2024 Aug; 260():155476. PubMed ID: 39038387 [TBL] [Abstract][Full Text] [Related]
13. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer. Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904 [TBL] [Abstract][Full Text] [Related]
14. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer. Zhu S; Mao J; Zhang X; Wang P; Zhou Y; Tong J; Peng H; Yang B; Fu Q Dig Liver Dis; 2024 Feb; 56(2):330-342. PubMed ID: 37400281 [TBL] [Abstract][Full Text] [Related]
15. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer. Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496 [TBL] [Abstract][Full Text] [Related]
16. MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis. Li L; Shang J; Zhang Y; Liu S; Peng Y; Zhou Z; Pan H; Wang X; Chen L; Zhao Q Oncol Rep; 2017 Sep; 38(3):1383-1392. PubMed ID: 28731151 [TBL] [Abstract][Full Text] [Related]
17. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity. Di Y; Jing X; Hu K; Wen X; Ye L; Zhang X; Qin J; Ye J; Lin R; Wang Z; He W Drug Resist Updat; 2023 Jan; 66():100909. PubMed ID: 36525936 [TBL] [Abstract][Full Text] [Related]
18. The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer. Wang H; Wang X; Zhang H; Deng T; Liu R; Liu Y; Li H; Bai M; Ning T; Wang J; Ge S; Ba Y Oncogene; 2021 Jul; 40(28):4695-4708. PubMed ID: 34140641 [TBL] [Abstract][Full Text] [Related]
19. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer. Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076 [TBL] [Abstract][Full Text] [Related]
20. GDF15 induces chemoresistance to oxaliplatin by forming a reciprocal feedback loop with Nrf2 to maintain redox homeostasis in colorectal cancer. Lin H; Luo Y; Gong T; Fang H; Li H; Ye G; Zhang Y; Zhong M Cell Oncol (Dordr); 2024 Aug; 47(4):1149-1165. PubMed ID: 38386232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]